
1. pathog glob health. 2014 oct;108(7):339-43. doi: 10.1179/2047773214y.0000000158. 
epub 2014 oct 27.

high prevalence pfmdr1 n86y y184f mutations plasmodium falciparum
isolates bioko island, equatorial guinea.

li j, chen j, xie d, monte-nguba sm, eyi ju, matesa ra, obono mm, ehapo cs, yang 
l, lu d, yang h, yang ht, lin m.

objective: drug resistance plasmodium falciparum recognized as
the crucial obstacle curbing mortality morbidity malaria. to
investigate distribution pattern multidrug resistance 1 (pfmdr1) gene 
polymorphisms p. falciparum, isolates collected malaria high-endemic 
bioko island, equatorial guinea.
methods: blood samples collected 217 patients p. falciparum
malaria rainy season 2012 bioko island. samples extracted
using chelex obtain parasite dna. nest-polymerase chain reaction (pcr) and
sequencing employed detect mutations (n86y, e130k, y184f, s1034c, n1042d,
v1109i, d1246y) haplotypes pfmdr1 gene.
results: total 151 samples successfully detected pfmdr1 mutations
from 217 patients. pfmdr1 mutations found 91·39% (138/151) p.
falciparum isolates. however, mutation 130 1109 identified from
these samples. four haplotypes coding 86, 184, 1034, 1,042, 1,246 found 
including nysnd, yysnd, nfsnd, yfsnd, accounted 8·61% (13/151),
2·65% (4/151), 29·80% (45/151), 58·94% (89/151), respectively.
conclusions: results exhibited hypersensitivity lumefantrine (lu) and
mefloquine (mq) resistance chloroquine (cq) amodiaquine (aq) p.
falciparum isolates bioko island. information useful for
anti-malarial drug policy equatorial guinea.

doi: 10.1179/2047773214y.0000000158 
pmcid: pmc4241786
pmid: 25348116  [indexed medline]

